Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1068837 ATLANTA, GA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$40,165,872
+$39,495,847 QoQ
Shares Held
127,071
+3686.4% QoQ
Ownership
0.637%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#40
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 91% None 9%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. LGND ranks #10 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 505,219 $250,957,432
2 PTGX
Protagonist Therapeutics, Inc
 571,618 $70,068,932
3 TWST
Twist Bioscience Corp
 671,866 $69,121,573
4 SRRK
Scholar Rock Holding Corp
 890,607 $48,983,385
5 KRYS
Krystal Biotech, Inc.
 124,442 $46,251,357
6 TGTX
Tg Therapeutics, Inc.
 819,253 $45,009,759
7 PTCT
Ptc Therapeutics, Inc.
 539,319 $43,992,249
8 PRAX
Praxis Precision Medicines, Inc.
 122,227 $40,920,376

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,165,872 127,071
2026-03-31 $670,025 3,356
2025-12-31 $651,724 3,447
2025-09-30 $610,601 3,447
2025-06-30 $588,407 5,176
2025-03-31 $499,415 4,750
2024-12-31 $553,322 5,164
2024-09-30 $556,300 5,558
2024-06-30 $480,450 5,702
2024-03-31 $411,114 5,624
2023-12-31 $486,084 6,806
2023-09-30 $403,321 6,731
2023-06-30 $478,095 6,631
2023-03-31 $425,691 5,787
2022-12-31 $386,571 5,787
2022-09-30 $498,318 5,787
2022-06-30 $516,315 5,787
2022-03-31 $674,827 5,999
2021-12-31 $909,769 5,890
2021-09-30 $1,282,161 9,203
2021-06-30 $1,221,378 9,310
2021-03-31 $1,475,105 9,676
2020-12-31 $946,763 9,520
2020-09-30 $755,696 7,928
2020-06-30 $655,440 5,860
2020-03-31 $628,736 8,646